To follow or not to follow dermatological treatment - A review of the literature

Acta Dermato-Venereologica

Volumn 86, Issue 3, 2006, Pages 193-197

  Serup, Jørgen ^a,e   Kettis Lindblad, Åsa ^b   Maroti, Marianne ^c   Kjellgren, Karin I ^d   Niklasson, Eva ^a   Ring, Lena ^b   Ahlner, Johan ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c RYHOV COUNTY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Adherence; Compliance; Concordance; Cream; Local therapy; Ointment; Solution

Indexed keywords

CORTICOSTEROID; TOPICAL AGENT;

ACNE; CLINICAL TRIAL; DOCTOR PATIENT RELATION; ECZEMA; HUMAN; LIFESTYLE; MEDICAL LITERATURE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF MEDICATION; SKIN DISEASE; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; CONFOUNDING FACTORS (EPIDEMIOLOGY); DERMATOLOGY; HUMANS; KERATOLYTIC AGENTS; PATIENT COMPLIANCE; QUESTIONNAIRES; SKIN DISEASES;

EID: 33745031617     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0073     Document Type: Review

References (35)

1. Sabate E. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organisation, 2003.
2. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43: 521-530.
3. Horne R. Compliance, adherence and concordance. In: Taylor K, Harding G, eds. Pharmacy practice. London: Taylor & Francis, 2001.
4. Finlay AY. The science of compliance, workshop abstracts 7th EADV Nice Congress. J Eur Acad Derm Venereol 1998; 11: 77-78.
5. Finlay AY. Dowling Oration 2000. Dermatology patients: what do they really need? Clin Exp Dermatol 2000; 25: 444-450.
6. Chren MM. Doctor's orders: rethinking compliance in dermatology. Arch Dermatol 2002; 138: 393-394.
7. Carroll CL, Feldman SR, Camacho FT, Balkrishnan R. Better medication adherence results in greater improvement in seventy of psoriasis. Br J Dermatol 2004; 151: 895-897.
8. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004; 51: 212-216.
9. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol 2004; 140: 408-414.
10. Renzi C, Picardi A, Abeni D, Agostini E, Baliva G, Pasquini P, et al. Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance. Arch Dermatol 2002; 138: 337-342.
11. Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41: 581-583.
12. van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000; 200: 292-298.
13. Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001; 117: 852-857.
14. Renzi C, Abeni D, Picardi A, Agostini E, Melchi CF, Pasquini P, et al. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001; 145: 617-623.
15. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000; 142: 931-936.
16. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127: 13-17.
17. Jobling RG. Psoriasis - a preliminary questionnaire study of sufferers' subjective experience. Clin Exp Dermatol 1976; 1: 233-236.
18. Osborne JE, Hutchinson PE. The importance of accurate dosage of topical agents: a method of estimating involved area and application to calcipotriol treatment failures. J Eur Acad Dermatol Venereol 2002; 16: 367-373.
19. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003; 149: 582-589.
20. Draelos ZK. Patient compliance: enhancing clinician abilities and strategies. J Am Acad Dermatol 1995; 32: 42-48.
21. Basak PY, Ozturk M, Baysal V. Assessment of information and education about topical corticosteroids in dermatology outpatient departments: experience from Turkey. J Eur Acad Dermatol Venereol 2003; 17: 652-658.
22. Broberg A, Kalimo K, Lindblad B, Swanbeck G. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol 1990; 70: 495-499.
23. Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432-439.
24. Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002; 13: 84-90.
25. Blichmann CW, Serup J, Winther A. Effects of single application of a moisturizer: evaporation of emulsion water, skin surface temperature, electrical conductance, electrical capacitance, and skin surface (emulsion) lipids. Acta Derm Venereol 1989; 69: 327-330.
26. Ivens UI, Steinkjer B, Serup J, Tetens V. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001; 145: 264-267.
27. Long CC, Finlay AY. The finger-tip unit - a new practical measure. Clin Exp Dermatol 1991; 16: 444-447.
28. Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: an overview. Br J Dermatol 1998; 139: 763-766.
29. Miller JJ, Roling D, Margolis D, Guzzo C. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis. J Am Acad Dermatol 1999; 41: 546-549.
30. Wester RC, Maibach HI. Regional variations in percutaneous absorption. In: Bronough RL, Maibach HI, eds. Percutaneous absorption. Basel: Marcel Decker; 1989: p. 111-120.
31. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090; discussion 1073.
32. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003; 49: 651-654.
33. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002: CD000011.
34. Kjellgren K, Ring L, Kettis Lindblad Å, Maroti M, Serup J. To follow dermatological treatment regimens - patients' and providers' views. Acta Derm Venereol 2004; 84: 445-450.
35. Kettis Lindblad Å, Kjellgren KI, Ring L, Maroti M, Serup J. The role of dermatologists, nurses and pharmacists in chronic dermatological treatment: Patient and provider views and experiences. Acta Derm Venereol, 2006; 86: 202-208.